Stock screenerAll disclosures →
EDGAR →
RLAY
Conviction 100HealthcareScan · Mon, Aug 10, 2026RLAY$19.94+0.83%
ResistanceSupportVol 14Insider sell2
5
Vol MA14 2.66M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price19.94
Change+0.83%
Gap-0.94%
Rel volume4.57×
Avg volume2.56M
Avg $ vol49.36M
SMA 2019.21
SMA 5017.70
SMA 20011.74
Price vs 50+12.62%
Price vs 200+69.81%
MA stackbullish
50/200 cross—
Supertrendup · 16.85
RSI (14)61
MACD hist-0.02
MACD cross—
Stoch %K / %D74 / 77
ADX (14)26
+DI / −DI27 / 16
RSI divergence—
MACD divergence—
ATR %+5.46%
ADR %5.40%
52w high20.75
52w low3.22
From 52w high-3.93%
Above 52w low+519.10%
New 52w highNo
SqueezeOn · 8d
Bollinger width10.39%
%B0.86
Donchian pos74.17%
Donchian high20.71
Donchian low17.71
AVWAP (52w high)19.41
vs AVWAP high+2.68%
AVWAP (52w low)11.66
vs AVWAP low+70.90%
OBV trendUp
Chaikin MF (20)-0.04
Today vs 20d4.57×
Avg vol (14d)2.66M
Avg vol (20d)2.56M
Avg $ vol (20d)49.36M
Market cap4.37B
RS 3m (vs SPY)+52.34%
RS 6m (vs SPY)+128.46%
RS line new highNo
Trend template8/8
Technical rank90.0
1 week+6.15%
1 month-0.35%
3 months+56.23%
6 months+123.49%
1 year+471.20%
YTD+143.70%
P/E-15.80
P/B4.91
P/S284.51
P/FCF-18.52
EPS-1.61
Div yield—
ROE-31.06%
ROA-28.58%
Debt/Eq—
Current18.27
EV/EBITDA—
Gross margin—
Net margin—
Rev growth53.44%
EPS growth18.13%
Price target26.20
Target upside31.43%
Analyst ratingBuy
Institutional94.15%
Ent. value4.25B
Revenue350K
Net income-83.71M
Gross profit—
Free cash flow-235.87M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out191.59M
Employees192
ListedThu, Jul 16, 2020
Free float116.71M
Float %65.3%
Short interest42.56M
Days to cover13.4d
Short volume78.2%
Squeeze score100 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.41 vs −$0.41
Last surprise0.0% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank90.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.59
Support17.69
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RLAY
No recent disclosed trades by Congress in RLAY. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RLAY · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Patel Sanjiv President and CEO · Common Stock · 2026-07-07 | Sell | 48.2K | $944K | 2026-07-07 | 2026-07-08 |
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-07-06 | Sell | 17.72K | $331K | 2026-07-06 | 2026-07-08 |
Bergstrom Donald A President, R&D · Common Stock · 2026-07-06 | Sell | 8.66K | $162K | 2026-07-06 | 2026-07-08 |
Patel Sanjiv President and CEO · Common Stock · 2026-06-30 | Grant | 3.06K | $21K | 2026-06-30 | 2026-07-08 |
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-06-22 | Sell | 17.72K | $301K | 2026-06-22 | 2026-06-24 |
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-06-22 | Exercise | 56.32K | $284K | 2026-06-22 | 2026-06-24 |
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-06-22 | Sell | 56.32K | $956K | 2026-06-22 | 2026-06-24 |
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-06-22 | Exercise | 61.56K | $321K | 2026-06-22 | 2026-06-24 |
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-06-22 | Sell | 61.56K | $1.0M | 2026-06-22 | 2026-06-24 |
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-06-22 | Exercise | 51.56K | $229K | 2026-06-22 | 2026-06-24 |
SEC filings
EDGAR filings in RLAY · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.